Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis
Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis
复制标题
肠道丁酸盐代谢物种有助于类风湿关节炎中自身抗体的产生和骨侵蚀
DOI:
10.1126/sciadv.abm1511
复制
发表时间:
2022-02-01
期刊:
影响因子:
13.6
通讯作者:
Li, Zhanguo
中科院分区:
文献类型:
--
作者:
He, Jing;Chu, Yanan;Li, Zhanguo
The imbalance between pathogenic and beneficial species of the intestinal microbiome and metabolism in rheumatoid arthritis (RA) remains unclarified. Here, using shotgun-based metagenome sequencing for a treatment-naive patient cohort and a "quasi-paired cohort" method, we observed a deficiency of butyrate-producing species and an overwhelming number of butyrate consumers in RA patients. These outcomes mainly occurred in patients with positive ACPA, with a mean AUC of 0.94. This panel was also validated in established RA with an AUC of 0.986 in those with joint deformity. In addition, we showed that butyrate promoted T-regs, while suppressing T-convs and osteoclasts, due to potentiation of the reduction in HDAC expression and down-regulation of proinflammatory cytokine genes. Dietary butyrate supplementation conferred anti-inflammatory benefits in a mouse model by rebalancing T-FH cells and T-regs, as well as reducing antibody production. These findings reveal the critical role of butyrate-metabolizing species and suggest the potential of butyrate-based therapies for RA patients.